China CAS:65928-58-7 Manufacturer

We are going to make every single effort for being excellent and excellent, and accelerate our ways for standing while in the rank of international top-grade and high-tech enterprises for CAS:65928-58-7, We welcome clients, enterprise associations and mates from all parts in the world to speak to us and search for cooperation for mutual positive aspects.
CAS:65928-58-7, We take measure at any expense to achieve essentially the most up-to-date equipment and approaches. The packing of nominated brand is our a further distinguishing feature. The products to assure years of trouble-free service has attracted a great deal customers. The solutions are obtainable in improved designs and richer assortment, they're created scientifically of purely raw supplies. It readily available in a variety of designs and specs for your selection. The most recent kinds are a great deal better than the preceding one particular and they are quite popular with lots of prospects.

Hot Products

  • Tibolone

    Tibolone

    Tibolone complies with EP specification. DMF is approved.

    CAS:5630-53-5

  • Eplerenone

    Eplerenone

    Eplerenone has EP specifications. CEP available and FDA approved.

    CAS:107724-20-9

  • Valganciclovir Hydrochloride

    Valganciclovir Hydrochloride

    Valganciclovir Hydrochloride has USP specification. DMF approved.

    CAS:175865-59-5

  • Cbz-Valganciclovir

    Cbz-Valganciclovir

    Cbz-Valganciclovir,N-Carbobenzyloxy-L-valinyl-ganciclovir (cas# 194154-40-0) is a compound useful in organic synthesis.

    CAS:194154-40-0

  • Mifepristone Capsules

    Mifepristone Capsules

    Mifepristone Capsules Specifications:10mg*1
    Indications:Emergency Contraceptive
  • 4-aza-5α-androstan-1-ene-3-oxo-17β-carboxylic acid

    4-aza-5α-androstan-1-ene-3-oxo-17β-carboxylic acid

    4-aza-5α-androstan-1-ene-3-oxo-17β-carboxylic acid is an intermediate of Dutasteride.

    CAS:103335-55-3

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept